Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02048774 · ClinicalTrials.gov registry record · NA
Leader Partner Interactions
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02048774: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT02048774 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02048774, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
Obesity is often cited as being inversely related with socioeconomic status (SES), although the mechanisms linking social status with obesity are not well understood. Dietary restraint, physical activity, and social mobility have been proposed as possible mechanisms. Although there is some evidence of SES variation in the proposed mechanisms, evidence is mixed and mostly observational. The purpose of this research is to determine if one's social position influences eating behaviors. This study will attempt to determine this using a randomized, 2 parallel arm trial to determine the effects that social hierarchy positioning has on energy intake. To prevent compromise in the integrity of data, the investigators will detail the exact treatment condition (i.e., social positioning) after the data collection period. Based on findings from previous animal and large clinical observational studies, there are two complementary hypotheses tested in this study. First, it is hypothesized that being in a lower social position affects one's perception of food availability by making the future availability of food seem less certain. This uncertainty will lead to increased food consumption. Second, it is hypothesized that being in a position of power will lower one's food consumption, as previous research has found that individuals in power tend to east less in groups. Understanding how social position influences food intake could help improve weight loss/maintenance interventions by identifying unexpected factors that could limit the intervention's effectiveness.
Interventions
- BEHAVIORAL Designation of Social Positioning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02048774 record still lists
NCT02048774 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Designation of Social Positioning is the first listed.
NCT02048774 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02048774 about?
NCT02048774 is a clinical study titled "Leader Partner Interactions". Obesity is often cited as being inversely related with socioeconomic status (SES), although the mechanisms linking social status with obesity are not well understood. Dietary restraint, physical activity, and social mobility have been proposed as possible mechanisms. Although there is some evidence ...
What is the current status of trial NCT02048774?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2014-02. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02048774?
The interventions under investigation include: Designation of Social Positioning (BEHAVIORAL).
Who is sponsoring clinical trial NCT02048774?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02048774's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia